Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Foster Goss, DO, MMSc, FACEP, an adjunct professor and site principal investigator for this study at the University of Colorado Anschutz Department of Emergency Medicine, co-authored a research letter on the study, published recently in JAMA Health Forum
A class action treats many similar claims as one case with a shared outcome, while a multi-district litigation (MDL) groups similar lawsuits for efficiency but keeps each case separate
20(S)-hydroxycholesterol inhibits PPAR expression and adipogenic differentiation of bone marrow stromal cells through a hedgehog-dependent mechanism
Though it took decades of testing and evaluation, exenatide, a synthetic version of exendin-4 was approved by the FDA in 2005 to treat Type-2 diabetes
US$ 22.78
US$ 25.18
US$ 29.00
US$ 22.61
